Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
EJ FÖR DISTRIBUTION DIREKT ELLER INDIREKT, INOM ELLER TILL AUSTRALIEN, HONGKONG, JAPAN, KANADA, NYA ZEELAND, SCHWEIZ, SINGAPORE, SYDAFRIKA ELLER USA, ELLER I NÅGON ANNAN JURISDIKTION DÄR...
-
NOT FOR DISTRIBUTION DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES, OR IN ANY OTHER JURISDICTION...
-
UPPSALA, SWEDEN – årsstämman i LIDDS AB (publ) hölls den 17 maj, 2021 Årsstämman fastställde i årsredovisningen intagen resultaträkning och balansräkning samt...
-
UPPSALA, SWEDEN – LIDDS Annual General Meeting (AGM) was held on May 17, 2021. The AGM adopted the income statement and balance sheet and the consolidated income statement...
-
JANUARY – MARCH 2021 Net sales amounted to MSEK 0.6 (0.0)Operating expenses amounted to MSEK -11.4 (-8.0)Profit/loss before and after tax amounted to MSEK -10.8 (-8.0)Earnings per share amounted to...
-
UPPSALA, SWEDEN – LIDDS publishes Annual Report for 2020 The Annual Report is attached to this press release and alos available on LIDDS website: https://liddspharma.com/investors/#financial-reports....
-
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that an application for a new clinical study at Uppsala University Hospital has been submitted. The study will assess intratumoral injections of...
-
UPPSALA, SWEDEN - Aktieägarna i LIDDS AB (publ), org.nr. 556580-2856, kallas till årsstämma i bolagets lokaler på Uppsala Business Park med besöksadress Rapsgatan 7 i Uppsala måndagen den 17 maj 2021...
-
UPPSALA, SWEDEN – The shareholders of LIDDS AB (publ), corp. ID no. 556580-2856, are invited to the Annual General Meeting in the company's premises at Uppsala Business Park with visiting address...
-
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that the journal International Journal of Pharmaceutics has accepted a biomolecule study from LIDDS for publication. The investigation has been...